Tango Therapeutics logo

Tango Therapeutics Share Price Today (NASDAQ: TNGX)

Tango Therapeutics share price is $4.69 & ₹403.64 as on 14 Jun 2025, 01.29 hrs IST

$4.69

-0.36

(-7.13%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Tango Therapeutics share price in Dollar and Rupees. Guide to invest in Tango Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tango Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Tango Therapeutics share price movements

  • Today's Low: $4.61
    Today's High: $5.05

    Day's Volatility :8.71%

  • 52 Weeks Low: $1.03
    52 Weeks High: $12.02

    52 Weeks Volatility :91.43%

Tango Therapeutics (TNGX) Returns

PeriodTango Therapeutics IncIndex (Russel 2000)
3 Months
140.51%
0.0%
6 Months
58.98%
0.0%
1 Year
-47.48%
0.0%
3 Years
14.67%
3.6%

Tango Therapeutics (TNGX) Key Statistics

in dollars & INR

Previous Close
$5.05
Open
$4.89
Today's High
$5.05
Today's Low
$4.61
Market Capitalization
$513.8M
Today's Volume
$2.4M
52 Week High
$12.015
52 Week Low
$1.03
Revenue TTM
$41.0M
EBITDA
$-143.4M
Earnings Per Share (EPS)
$-1.37
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-61.35%

How to invest in Tango Therapeutics Stock (TNGX) from India?

It is very easy for Indian residents to invest directly in Tango Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tango Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tango Therapeutics or TNGX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tango Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tango Therapeutics shares which would translate to 0.184 fractional shares of Tango Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Tango Therapeutics, in just a few clicks!

Returns in Tango Therapeutics (TNGX) for Indian investors in Rupees

The Tango Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tango Therapeutics investment value today

Current value as on today

₹55,558

Returns

₹44,442

(-44.44%)

Returns from Tango Therapeutics Stock

₹47,480 (-47.48%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Tango Therapeutics (TNGX)

1600.0%

Period: May 14, 2025 to Jun 13, 2025. Change in 30 Days versus previous period

Investment in Tango Therapeutics Shares from India has grown by 1600.0% over the past 30 days, indicating increased transactional activity.

29%

Period: May 14, 2025 to Jun 13, 2025. Change in 30 Days versus previous period

Search interest for Tango Therapeutics Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tango Therapeutics

  • TRV GP IV, LLC

    15.55%

  • TCG Crossover Management, LLC

    9.90%

  • EcoR1 Capital, LLC

    9.81%

  • Boxer Capital Management, LLC

    9.58%

  • Nextech Invest AG

    5.11%

  • Farallon Capital Management, L.L.C.

    4.25%

Analyst Recommendation on Tango Therapeutics

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Tango Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Tango Therapeutics Stock (TNGX)

What analysts predicted

Upside of 122.36%

Target:

$10.43

Current:

$4.69

Insights on Tango Therapeutics Stock (Ticker Symbol: TNGX)

  • Price Movement

    In the last 1 month, TNGX stock has moved up by 265.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 4.11M → 5.39M (in $), with an average increase of 23.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -25.55M → -39.87M (in $), with an average decrease of 16.4% per quarter
  • TNGX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 139.2%
  • TNGX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 130.3% return, outperforming this stock by 111.9%
  • Price to Sales

    ForTNGX every $1 of sales, investors are willing to pay $12.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Tango Therapeutics Technicals Summary

Sell

Neutral

Buy

Tango Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Tango Therapeutics (TNGX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Tango Therapeutics Inc logo
208.55%
58.98%
-47.48%
14.67%
-53.05%
Regeneron Pharmaceuticals, Inc. logo
-9.61%
-27.05%
-48.98%
-5.77%
-10.46%
Beone Medicines Ltd logo
19.44%
52.93%
65.87%
97.21%
57.25%
Vertex Pharmaceuticals Incorporated logo
4.88%
-2.68%
-5.24%
79.7%
70.13%
Alnylam Pharmaceuticals, Inc. logo
8.48%
26.01%
91.68%
126.98%
139.48%

About Tango Therapeutics

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase 11 loss-of-function mutations for treating lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Organization
Tango Therapeutics
Employees
155
CEO
Dr. Barbara L. Weber M.D.
Industry
Miscellaneous

Management People of Tango Therapeutics

NameTitle
Dr. Barbara L. Weber M.D.
President, CEO & Director
Ms. Daniella Beckman CPA
Chief Financial Officer
Mr. Douglas J. Barry Esq., J.D.
Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Dr. Adam S. Crystal M.D., Ph.D.
President of Research & Development
Prof. Alan Ashworth FRS, Ph.D.
Founder & Member of Scientific Advisory Board
Dr. William G. Kaelin Jr., M.D.
Founder & Member of Scientific Advisory Board
Dr. Antoni Ribas M.D., Ph.D.
Founder & Member of Scientific Advisory Board
Dr. Michael Palmieri Ph.D.
Head of Technical Operations
Mr. Jannik N. Andersen Ph.D.
Chief Scientific Officer
Ms. Elizabeth Pingpank Hickin
VP of IR & Corporate Communications

Important FAQs about investing in TNGX Stock from India :

Can Indians buy Tango Therapeutics shares?

Yes, Indians can invest in the Tango Therapeutics (TNGX) from India.

With INDmoney, you can buy Tango Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tango Therapeutics at zero transaction cost.

How can I buy Tango Therapeutics shares from India?

It is very easy to buy Tango Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tango Therapeutics (TNGX) be purchased?

Yes, you can buy fractional shares of Tango Therapeutics with INDmoney app.

What are the documents required to start investing in Tango Therapeutics stocks?

To start investing in Tango Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Tango Therapeutics share price today?

Tango Therapeutics share price today stands at $4.69, Open: $4.89 ; Previous Close: $5.05 ; High: $5.05 ; Low: $4.61 ; 52 Week High: $12.02 ; 52 Week Low: $1.03.

The stock opens at $4.89, after a closing price of $5.05. The stock reached a daily high of $5.05 and a low of $4.61, with a 52-week high of $12.02 and a 52-week low of $1.03.

What are today’s High and Low prices of Tango Therapeutics Stock (TNGX)?

Today’s highest price of Tango Therapeutics (TNGX) is $5.05.

Today’s lowest price of Tango Therapeutics (TNGX) is $4.61.

What is the 52 Week High and Low Range of Tango Therapeutics Stock (TNGX)?

  • 52 Week High

    $12.02

  • 52 Week Low

    $1.03

What are the historical returns of Tango Therapeutics (TNGX)?

  • 1 Month Returns

    208.55%

  • 3 Months Returns

    58.98%

  • 1 Year Returns

    -47.48%

  • 5 Years Returns

    -53.05%

What is today's market capitalisation of Tango Therapeutics?

Today's market capitalisation of Tango Therapeutics TNGX is 513.8M

Who is the Chief Executive Officer (CEO) of Tango Therapeutics ?

Dr. Barbara L. Weber M.D. is the current Chief Executive Officer (CEO) of Tango Therapeutics.